Latest Alpha-synuclein Stories
AFFiRiS AG presents Phase I data on a first-of-its-kind treatment with support from The Michael J.
--Research Includes Stem Cells, Imaging and Exercise for Cognition-- MIAMI, May 22, 2014 /PRNewswire-USNewswire/ -- The National
EU support boosts development of therapeutic vaccines against Parkinson's and Multiple System Atrophy.
NEW YORK, April 23, 2014 /PRNewswire-USNewswire/ -- The Michael J.
As part of its $219,000 initial multiple system atrophy research grant funding round, The MSA Coalition® has awarded $25,00 to Dr.
The MSA Coalition announced in January 2014 the funding of five MSA research grants for a total of $219,000 including the project "Peripheral delivery of brain-targeted neurosin as a novel
NEW YORK, Feb. 25, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J.
The most devastating aspect of Parkinson's disease may not be its debilitating symptoms, which rob its victims of their ability to control their own movement.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.